Allogene Therapeutics
ALLO
ALLO
173 hedge funds and large institutions have $3.8B invested in Allogene Therapeutics in 2020 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 55 increasing their positions, 37 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
49% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 37
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
4.89% more ownership
Funds ownership: 59.05% → 63.94% (+4.9%)
Holders
173
Holding in Top 10
7
Calls
$15.9M
Puts
$9.13M
Top Buyers
| 1 | +$130M | |
| 2 | +$113M | |
| 3 | +$76.3M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$67.9M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$44.9M |
Top Sellers
| 1 | -$64.2M | |
| 2 | -$45.9M | |
| 3 | -$28.2M | |
| 4 |
VM
VV Manager
Boston,
Massachusetts
|
-$21.1M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$11.7M |